Constellation Brands (NYSE: STZ) reports Q2 FY2027 (June–August 2026, ca. October 3, 2026) organic beer segment net revenue growth exceeding 3.0% year-over-year
Hit
✦ AI-generated prediction
Published on 10. September 2026
·
Predicted for 3. October 2026
·
Based on: Historical Cycle
Constellation Brands (Modelo Especial — #1 US beer by volume; Corona Extra; Pacifico) showed weak growth in Q1 FY2027 (March–May 2026): total depletions +0.6%, Modelo Especial near -1%, Corona Extra -6%. Company FY2027 guidance: organic enterprise net sales -1% to +1%. However, Q2 (June–August 2026) benefits from two special tailwinds: FIFA World Cup social gatherings ('World Cup-fueled gatherings driving US beer demand', Constellation IR) and the summer consumption peak. Constellation also signals higher marketing spend (>10% of net sales) in Q2 and Q3, plus the Veracruz brewery nearing commissioning. These lift the beer segment growth above the weak Q1 figure. No prediction market available; calibration via historical seasonality patterns.
Data basis for this prediction
- Constellation Brands Q1 FY2027 (Mai 2026): Depletionen +0,6 %; Modelo Especial -1 %, Corona Extra -6 % (cbrands.com/SEC)
- Seeking Alpha/Constellation IR: Marketingausgaben >10 % Nettoumsatz Q2+Q3 FY2027; Veracruz-Brauerei nähert sich Betrieb (2026)
- MarketScreener/Constellation IR: 'World Cup-fueled gatherings driving US beer demand' – Katalysator Q2 FY2027
- cbrands.com Earnings-Kalender: Q2 FY2027 Ergebnisdatum ca. 3. Oktober 2026 (Geschäftsjahresende April 30)
Verdict: Hit
Constellation Brands veröffentlichte die Q2-FY2027-Ergebnisse am 7. Oktober 2026 (leicht nach dem erwarteten 3. Oktober). Das Biersegment erzielte einen Nettoumsatz von ca. 2,47 Mrd. USD, +5 % gegenüber dem Vorjahr; der organische Gesamtkonzernumsatz stieg um 6 %. Das organische Biersegmentwachstum von ~5 % lag damit klar über der Schwelle von >3,0 %. Treiber waren vor allem Shipment-Volumen (+5,5 %), das WM-Sommerhoch sowie die erhöhten Marketingausgaben – genau wie in der Vorhersage antizipiert. Belastend wirkten weiterhin schwache Depletions (–0,6 %; Modelo Especial –2 %, Corona Extra –5 %), die den Umsatzzuwachs aber nicht unter die Schwelle drückten. Quellen: Constellation Brands IR-Blog (cbrands.com), Yahoo Finance, Motley Fool Earnings Call Transcript (2026-10-07).
🍾 Beverages
✦ AI
Rémy Cointreau published its H1 FY2026/27 result on October 27, 2026: organic growth of +2.9 percent YoY for April–September 2026 — 90 basis points above this forecast's threshold. The company confirmed its FY2026/27 guidance ('gradual return to organic growth'). Q2 FY2026/27 (Jul–Sep): Cognac up 12 percent YoY. FY2025/26 full year: +0.2 percent organic ('in line with targets', Rémy IR, June 3, 2026). Achieving above 2.0 percent for the full year only requires H2 (Oct 2026–Mar 2027) to avoid a complete collapse — the 90-basis-point H1 buffer provides substantial safety margin. Risks: US demand weakness, Chinese Cognac tariffs, macro slowdown. Supporting: Rémy Martin premiumization strategy, confirmed guidance, strong Q2 momentum.
🍾 Beverages
✦ AI
After the record of 322 million bottles (2021), Champagne shipments are in structural decline: ~319 million in 2022, ~299 million in 2023 (CIVC). Continued luxury weakness in China (export volume –27% YoY H1 2026), rising input costs, and saturated key markets (USA, France, UK) point to further contraction. At –5 to –7% p.a. decline (2022–2025 trend), 2026 volume would be approximately 262–271 million bottles — well below the 280 million threshold. No prediction market signal available. Confirmed via CIVC annual report or Reuters by January 31, 2027.
🍾 Beverages
✦ AI
Analyst consensus for Q3 2026: EPS 0.2998 USD (~0.30 USD) with revenue of 2.49 billion USD (MarketBeat / TradingView, as of October 2026). Monster Beverage has beaten EPS consensus in a majority of recent quarters and continues to benefit from international market expansion in the energy drink segment. No active Polymarket or Kalshi market found for this event; beat probability estimated at ~65% based on historical beat rate and current consensus positioning.